A review of Gaucher disease pathophysiology, clinical presentation and treatments

J Stirnemann, N Belmatoug, F Camou… - International journal of …, 2017 - mdpi.com
Gaucher disease (GD, ORPHA355) is a rare, autosomal recessive genetic disorder. It is
caused by a deficiency of the lysosomal enzyme, glucocerebrosidase, which leads to an …

Gaucher disease in bone: from pathophysiology to practice

D Hughes, P Mikosch, N Belmatoug… - Journal of Bone and …, 2019 - academic.oup.com
Gaucher disease (GD) is a rare, genetic lysosomal disorder leading to lipid accumulation
and dysfunction in multiple organs. Involvement of the skeleton is one of the most prevalent …

Glucosylsphingosine promotes α-synuclein pathology in mutant GBA-associated Parkinson's disease

YV Taguchi, J Liu, J Ruan, J Pacheco… - Journal of …, 2017 - Soc Neuroscience
Glucocerebrosidase 1 (GBA) mutations responsible for Gaucher disease (GD) are the most
common genetic risk factor for Parkinson's disease (PD). Although the genetic link between …

Clonal immunoglobulin against lysolipids in the origin of myeloma

S Nair, AR Branagan, J Liu… - … England Journal of …, 2016 - Mass Medical Soc
Antigen-driven selection has been implicated in the pathogenesis of monoclonal
gammopathies. Patients with Gaucher's disease have an increased risk of monoclonal …

Glucosylsphingosine is a key biomarker of Gaucher disease

V Murugesan, WL Chuang, J Liu… - American journal of …, 2016 - Wiley Online Library
Gaucher disease (GD) involves the accumulation of glucosylceramide (GL1) and its
deacylated lysolipid, glucosylsphingosine (lyso‐GL1) which is implicated in mediating …

New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin

K Senkevich, U Rudakou, Z Gan-Or - Neuropharmacology, 2022 - Elsevier
Parkinson's disease (PD) is defined as a complex disorder with multifactorial pathogenesis,
yet a more accurate definition could be that PD is not a single entity, but rather a mixture of …

Value of glucosylsphingosine (Lyso-Gb1) as a biomarker in Gaucher disease: a systematic literature review

S Revel-Vilk, M Fuller, A Zimran - International journal of molecular …, 2020 - mdpi.com
The challenges in the diagnosis, prognosis, and monitoring of Gaucher disease (GD), an
autosomal recessive inborn error of glycosphingolipid metabolism, can negatively impact …

Gaucher disease: Progress and ongoing challenges

PK Mistry, G Lopez, R Schiffmann, NW Barton… - Molecular genetics and …, 2017 - Elsevier
Over the past decades, tremendous progress has been made in the field of Gaucher
disease, the inherited deficiency of the lysosomal enzyme glucocerebrosidase. Many of the …

Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian …

A Rolfs, AK Giese, U Grittner, D Mascher, D Elstein… - PloS one, 2013 - journals.plos.org
Background Gaucher disease (GD) is the most common lysosomal storage disorder (LSD).
Based on a deficient β-glucocerebrosidase it leads to an accumulation of glucosylceramide …

Recent advances in the diagnosis and management of Gaucher disease

SE Gary, E Ryan, AM Steward… - Expert review of …, 2018 - Taylor & Francis
Introduction: Gaucher disease, the autosomal recessive deficiency of the lysosomal enzyme
glucocerebrosidase, is associated with wide phenotypic diversity including non …